BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31477525)

  • 1. Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas.
    Covelli C; Parente P; Pepe F; Pisapia P; Fiordelisi F; Malapelle U
    Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):491-492. PubMed ID: 31477525
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Lupinacci RM; Goloudina A; Buhard O; Bachet JB; Maréchal R; Demetter P; Cros J; Bardier-Dupas A; Collura A; Cervera P; Scriva A; Dumont S; Hammel P; Sauvanet A; Louvet C; Delpéro JR; Paye F; Vaillant JC; André T; Closset J; Emile JF; Van Laethem JL; Jonchère V; Abd Alsamad I; Antoine M; Rodenas A; Fléjou JF; Dusetti N; Iovanna J; Duval A; Svrcek M
    Gastroenterology; 2018 Mar; 154(4):1061-1065. PubMed ID: 29158190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microsatellite instability of bilateral breast carcinomas is not linked to down-regulated expression of DNA mismatch repair genes].
    Kuligina ESh; Morreau N; Imianitov EN
    Vopr Onkol; 2010; 56(2):152-5. PubMed ID: 20552889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological predictors for microsatellite instability in urothelial carcinoma.
    Sobrino-Reig E; Meizoso T; García J; Varillas-Delgado D; Martin YB
    Diagn Pathol; 2021 Nov; 16(1):106. PubMed ID: 34801034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MICROSATELLITE INSTABILITY AND SURVIVAL IN PATIENTS WITH ENDOMETRIAL CANCER.].
    Ivanova K; Stoyanov S; Vlaykova T; Gulubova M
    Akush Ginekol (Sofiia); 2016; 55(5):21-28. PubMed ID: 29790711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostaining in the context of loss mismatch repair function: interpretive confounders and cautionary tales!
    Fadhil W; Field J; Cross G; Kaye P; Ilyas M
    Histopathology; 2012 Sep; 61(3):522-5. PubMed ID: 22642480
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors.
    Xicola RM; Llor X; Pons E; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Duque JM; Nicolás-Pérez D; Garcia AM; Rigau J; Gassull MA;
    J Natl Cancer Inst; 2007 Feb; 99(3):244-52. PubMed ID: 17284719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors.
    Arnason T; Sapp HL; Rayson D; Barnes PJ; Drewniak M; Nassar BA; Huang WY
    Arch Pathol Lab Med; 2011 Dec; 135(12):1539-44. PubMed ID: 22129180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
    Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
    Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.
    Smyth EC; Wotherspoon A; Peckitt C; Gonzalez D; Hulkki-Wilson S; Eltahir Z; Fassan M; Rugge M; Valeri N; Okines A; Hewish M; Allum W; Stenning S; Nankivell M; Langley R; Cunningham D
    JAMA Oncol; 2017 Sep; 3(9):1197-1203. PubMed ID: 28241187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical examination of MSH2, PMS2, MLH1, MSH6 compared with the analysis of microsatellite instability in colon adenocarcinoma].
    Raskin GA; Ianus GA; Kornilov AV; Orlova RV; Petrov SV; Protasova AÉ; Pozharisskiĭ KM; Imianitov EN
    Vopr Onkol; 2014; 60(2):47-50. PubMed ID: 24919261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
    Usha L; Dewdney SB; Buckingham LE
    JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347
    [No Abstract]   [Full Text] [Related]  

  • 13. Altered expression of mismatch repair proteins associated with acquisition of microsatellite instability in a clonal model of human T lymphocyte aging.
    Neri S; Pawelec G; Facchini A; Ferrari C; Mariani E
    Rejuvenation Res; 2008 Jun; 11(3):565-72. PubMed ID: 18484899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases.
    Diniz G; Aktas S; Cubuk C; Ortac R; Vergin C; Olgun N
    Pediatr Hematol Oncol; 2013 May; 30(4):273-84. PubMed ID: 23570624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Null-pattern' mismatch repair enzyme immunostaining in a sporadic microsatellite-unstable colorectal carcinoma with biallelic somatic MSH6 gene aberrations.
    Hühns M; Prall F
    Histopathology; 2021 Jan; 78(2):340-342. PubMed ID: 32939843
    [No Abstract]   [Full Text] [Related]  

  • 16. Population bias in somatic measurement of microsatellite instability status.
    Saul M; Poorman K; Tae H; Vanderwalde A; Stafford P; Spetzler D; Korn WM; Gatalica Z; Swensen J
    Cancer Med; 2020 Sep; 9(17):6452-6460. PubMed ID: 32644297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
    Zakout YM; Lanza G
    J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer.
    Ji X; Sui L; Song K; Lv T; Zhao H; Yao Q
    Cancer Med; 2021 Jul; 10(14):4743-4751. PubMed ID: 34076351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interobserver Agreement for Mismatch Repair Protein Immunohistochemistry in Endometrial and Nonserous, Nonmucinous Ovarian Carcinomas.
    Sari A; Pollett A; Eiriksson LR; Lumsden-Johanson B; Van de Laar E; Kazerouni H; Salehi A; Sur M; Lytwyn A; Ferguson SE
    Am J Surg Pathol; 2019 May; 43(5):591-600. PubMed ID: 30864976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
    Karahan B; Argon A; Yıldırım M; Vardar E
    Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.